Skip to main content

Table 4 Toxicities experienced by the patients

From: Results of a phase II open-label, non-randomized trial of cisplatin chemotherapy in patients with BRCA1-positive metastatic breast cancer

Toxicity

N (%)

Neutropenia

 

Grade 1

1

Grade 2

4

Grade 3

1

Grade 4

1

Any

7 (35%)

Nausea/vomiting

 

Grade 1

4

Grade 2

6

Any

10 (50%)

Anemia

 

Grade 1

0

Grade 2

0

Grade 3

1

Any

1 (5%)

Neurotoxicity

 

Grade 1

2

Grade 2

4

Grade 3

0

Grade 4

0

Any

6 (30%)

Back to article page

Breast Cancer Research

ISSN: 1465-542X

Contact us